Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

In a first-of-its-kind surgery, a team led by a University of Maryland Medical Center (UMMC) neurosurgeon has successfully ...

Neurosurgeons at the University of Maryland Medical Center in the U.S. have achieved a groundbreaking milestone by ...